Intervention Review

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

  1. Colin Chalk1,*,
  2. Tim J Benstead2,
  3. Fraser Moore3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 21 AUG 2007

DOI: 10.1002/14651858.CD004572.pub2

Database Title

Additional Information

How to Cite

Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD004572. DOI: 10.1002/14651858.CD004572.pub2.

Author Information

  1. 1

    McGill University, Medicine and Neurology & Neurosurgery, Montreal, Quebec, Canada

  2. 2

    Dalhousie University/Capital Health, Medicine, Halifax, Nova Scotia, Canada

  3. 3

    McGill University, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada

*Colin Chalk, Medicine and Neurology & Neurosurgery, McGill University, Montreal General Hospital - Room L7-313, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada. colin.chalk@mcgill.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (60K)Standard (364K)Full (455K)

  1. Current Version

    Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

    Colin Chalk, Tim J Benstead and Fraser Moore

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004572.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

    C Chalk, TJ Benstead and F Moore

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD004572

View Full Article (HTML) Summary (60K)Standard (364K)Full (455K)